Search
carbapenem-resistant Acinetobacter
Epidemiology:
- carbapenem-resistant Acinetobacter fastest increasing etiology of nosocomial pneumonia 2019-2020 [1]
Pathology:
- nosocomial pneumonia
Laboratory:
- carbapenemase resistance gene
- carbapenemase in isolate
Management:
- Carbapenem-resistant Acinetobacter baumannii
- durlobactam sulbactam in combination with meropenem or imipenem-cilastatin [2]
Related
carbapenem (thienamycin)
General
Acinetobacter
References
- Rapid Review Quiz: Hospital-Acquired Pneumonia
Medscape. Sept 15, 2022
https://reference.medscape.com/viewarticle/980567
- Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA.
Infectious Diseases Society of America 2024 Guidance on the Treatment of
Antimicrobial-Resistant Gram-Negative Infections.
Clin Infect Dis. 2024 Aug 7:ciae403.
PMID: 39108079
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciae403/7728556